These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28362701)

  • 61. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
    Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO
    Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MYC protein expression is an important prognostic factor in acute myeloid leukemia.
    Ohanian M; Rozovski U; Kanagal-Shamanna R; Abruzzo LV; Loghavi S; Kadia T; Futreal A; Bhalla K; Zuo Z; Huh YO; Post SM; Ruvolo P; Garcia-Manero G; Andreeff M; Kornblau S; Borthakur G; Hu P; Medeiros LJ; Takahashi K; Hornbaker MJ; Zhang J; Nogueras-González GM; Huang X; Verstovsek S; Estrov Z; Pierce S; Ravandi F; Kantarjian HM; Bueso-Ramos CE; Cortes JE
    Leuk Lymphoma; 2019 Jan; 60(1):37-48. PubMed ID: 29741984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemia.
    Chen P; Redd L; Schmidt Y; Koduru P; Fuda F; Montgomery-Goecker C; Kumar K; Xu-Monette Z; Young K; Collins R; Chen W
    Leuk Res; 2021 Jul; 106():106584. PubMed ID: 33933715
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
    Zhang S; Zhang Q; Shi G; Yin J
    Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation.
    Mizuno H; Koya J; Masamoto Y; Kagoya Y; Kurokawa M
    Cancer Sci; 2021 Oct; 112(10):4112-4126. PubMed ID: 34363719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience.
    Teoh CS; Lee SY; Chiang SK; Chew TK; Goh AS
    Asian Pac J Cancer Prev; 2018 May; 19(5):1229-1236. PubMed ID: 29801406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
    Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
    Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.
    Högstrand K; Hejll E; Sander B; Rozell B; Larsson LG; Grandien A
    PLoS One; 2012; 7(2):e31366. PubMed ID: 22393362
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia.
    Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH
    Leuk Lymphoma; 2014 Jan; 55(1):110-20. PubMed ID: 23647058
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC).
    Yun S; Sharma R; Chan O; Vincelette ND; Sallman DA; Sweet K; Padron E; Komrokji R; Lancet JE; Abraham I; Moscinski LC; Cleveland JL; List AF; Zhang L
    Leuk Res; 2019 Sep; 84():106194. PubMed ID: 31357093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study.
    Wagner S; Vadakekolathu J; Tasian SK; Altmann H; Bornhäuser M; Pockley AG; Ball GR; Rutella S
    Blood Adv; 2019 Apr; 3(8):1330-1346. PubMed ID: 31015209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. EVI1 expression in acute myeloid leukaemia.
    Langabeer SE; Rogers JR; Harrison G; Wheatley K; Walker H; Bain BJ; Burnett AK; Goldstone AH; Linch DC; Grimwade D;
    Br J Haematol; 2001 Jan; 112(1):208-11. PubMed ID: 11167805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
    Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
    J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
    Verhaak RG; Valk PJ
    Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 80. GAS6 expression identifies high-risk adult AML patients: potential implications for therapy.
    Whitman SP; Kohlschmidt J; Maharry K; Volinia S; Mrózek K; Nicolet D; Schwind S; Becker H; Metzeler KH; Mendler JH; Eisfeld AK; Carroll AJ; Powell BL; Carter TH; Baer MR; Kolitz JE; Park IK; Stone RM; Caligiuri MA; Marcucci G; Bloomfield CD
    Leukemia; 2014 Jun; 28(6):1252-1258. PubMed ID: 24326683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.